Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01595282 · ClinicalTrials.gov registry record · NA

Intramuscular Ketorolac Versus Oral Ibuprofen for Pain Relief in First Trimester Suction Curettage

A NA study, sponsored by Planned Parenthood League of Massachusetts.

Completed
Registry status
NA
Development phase
94
Enrollment target

NCT01595282 is a NA study that has completed, run by Planned Parenthood League of Massachusetts. The registered enrollment target is 94 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01595282, a NA study, has completed, sponsored by Planned Parenthood League of Massachusetts.

COMPLETED
Registry status
NA
Development phase
94 participants
Enrollment target

Study Summary

The aim of this study is to compare the effect of pre-procedural ketorolac to ibuprofen on immediate post-procedural pain scores in patients undergoing first trimester suction curettage with local anesthesia only. Our primary hypothesis is that IM ketorolac compared to oral ibuprofen will result in an approximate 30% reduction in pain scores on a 21-point numerical rating scale immediately after the procedure. Secondary hypotheses include: * Pain scores on the 21-point scale will also be significantly lower in the ketorolac group immediately after cervical dilation and 15 minutes post-procedure. * Fewer patients in the ketorolac group will rate their pain as "severe" on a subjective pain rating scale. * Patients in the ketorolac group will be more satisfied with their pain control. * Side effects will be similar between groups.

Interventions

  • DRUG Ketorolac
  • DRUG Ibuprofen

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2011-06
Est. Completion 2012-06
Phase NA

What the Registry Record Tells You About NCT01595282

The ClinicalTrials.gov registry entry for NCT01595282 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Planned Parenthood League of Massachusetts, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Ketorolac is the first listed.

NCT01595282 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01595282 about?

NCT01595282 is a clinical study titled "Intramuscular Ketorolac Versus Oral Ibuprofen for Pain Relief in First Trimester Suction Curettage". The aim of this study is to compare the effect of pre-procedural ketorolac to ibuprofen on immediate post-procedural pain scores in patients undergoing first trimester suction curettage with local anesthesia only. Our primary hypothesis is that IM ketorolac compared to oral ibuprofen will result in...

What is the current status of trial NCT01595282?

This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2011-06. Estimated completion is 2012-06.

What interventions are being tested in trial NCT01595282?

The interventions under investigation include: Ketorolac (DRUG), Ibuprofen (DRUG).

Who is sponsoring clinical trial NCT01595282?

This trial is sponsored by Planned Parenthood League of Massachusetts, which has 13 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.